Stock EXAS EXACT SCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
44.09 USD -2.43% Intraday chart for Exact Sciences Corporation +3.91% -40.40%
Jun. 27 Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target MT
Jun. 26 BTIG Lowers Price Target on Exact Sciences to $70 From $80, Maintains Buy Rating MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Exact Sciences schedules second quarter 2024 earnings call
BU
Geneoscopy Files Counterclaims against Exact Sciences
AQ
Exact Sciences : EEO-1 for the FY ended 12/19/2023
PU
Exact Sciences : EEO-1 for the FY ended 12/19/2022
PU
Exact Sciences : EEO-1 for the FY ended 12/19/2021
PU
Exact Sciences : EEO-1 for the FY ended 12/29/2020
PU
Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target
MT
BTIG Lowers Price Target on Exact Sciences to $70 From $80, Maintains Buy Rating
MT
Exact Sciences Seeks Acquisitions
CI
Transcript : Exact Sciences Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 03:20 PM
Biocartis NV Appoints Gina Wallar as Chief Business Officer
CI
Transcript : Exact Sciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 11:00 AM
Transcript : Exact Sciences Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 12:40 PM
Exact Sciences : Regulation FD Disclosure - Form 8-K
PU
Exact Sciences Corporation Reaffirms Earnings Guidance for the Second-Quarter 2024 and Full-Year 2024
CI
Exact Sciences Corporation Announces Resignation of Everett Cunningham, Chief Commercial Officer, Effective on June 13, 2024
CI
Exact Sciences to Participate in June Investor Conferences
BU
Sector Update: Health Care Stocks Advance Pre-Bell Friday
MT
Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test
MT
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. News Exact Sciences Corporation